Research

August 25, 2016

New fund honors spirit of Cohen’s innovative research

When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).

By Leigh MacMillan
August 25, 2016

VUMC lands NIH training grant in emergency care

Vanderbilt University Medical Center (VUMC) has received a five-year, $2 million award from the National Institutes of Health (NIH) to establish the Vanderbilt Emergency Care Research Training Program.

By VUMC News and Communications
chubby child playing with dog
August 25, 2016

Growth hormone for Prader-Willi

Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients.

By VUMC News and Communications
August 18, 2016

Program helps Ph.D. students find non-academic careers

In 2013, Vanderbilt University School of Medicine (VUSM) received one of 10 grants from the National Institutes of Health called BEST (Broadening Experiences in Scientific Training) to help train scientists for a variety of diverse careers.

By VUMC News and Communications
lungs
August 18, 2016

Major grant enhances pulmonary fibrosis research

Vanderbilt University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF).

By Kathy Whitney
August 17, 2016

New center will examine addiction at molecular level, develop treatments

Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.

By Bill Snyder
August 15, 2016

Foundation’s support speeds search for new schizophrenia drugs at Vanderbilt

Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation.
By Bill Snyder
August 15, 2016

In search of new asthma therapies

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.
By Leigh MacMillan
August 12, 2016

New culprit in nerve degeneration

Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies.
By Leigh MacMillan
August 11, 2016

NIH grant bolsters mass spectrometry research initiatives

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine.
By Bill Snyder
August 11, 2016

Team explores transcription factor’s autoimmunity role

Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently.
By Bill Snyder
August 11, 2016

Research team takes aim at Ebola virus ‘decoy protein’

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system.
By Bill Snyder
August 11, 2016

Transcription factor evolution

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.
By Sanjay Mishra
1 … 102 103 104 105 106 … 216